文献速递关节外科

慢性口服糖皮质激素使用与全膝关节置换术后10年主要并发症发生率

Chronic Oral Corticosteroid Use and 10-Year Incidence of Major Complications Following Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2024-04-20

基于全国数据库的回顾性队列分析显示,术前长期口服糖皮质激素的全膝关节置换术患者,10年内全因翻修、假体周围感染和脆性骨折的风险显著高于未使用激素者。

要点

  • 术前慢性口服激素患者10年全因翻修风险升高(HR 1.21,P=0.009)。
  • 假体周围感染风险升高(HR 1.30,P=0.045)。
  • 脆性骨折风险升高(HR 1.47,P<0.001)。

核心结论

  • 术前长期口服糖皮质激素的全膝关节置换术患者,术后10年内全因翻修、假体周围感染和脆性骨折风险高于未使用激素者。

研究设计与样本

  • 回顾性队列分析,使用全国数据库,纳入611,596例初次全膝关节置换术患者,其中5,217例(0.85%)术前长期使用口服糖皮质激素,随机抽取10,000例对照进行分析。

主要发现

  • 激素组10年脆性骨折风险显著高于对照组(HR 1.47;95%CI 1.34至1.62;P<0.001)。
  • 激素组10年全因翻修风险显著高于对照组(HR 1.21;95%CI 1.05至1.40;P=0.009)。
  • 激素组10年假体周围感染风险显著高于对照组(HR 1.30;95%CI 1.01至1.69;P=0.045)。

临床怎么用

  • 作者认为,该信息可用于术前咨询,向这一高危患者群体说明术后并发症风险增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oral corticosteroids are the primary treatment for several autoimmune conditions. The risk of long-term implant, bone health, and infectious-related complications in patients taking chronic oral corticosteroids before total knee arthroplasty (TKA) is unknown. We compared the 10-year cumulative incidence of revision, periprosthetic joint infection (PJI), fragility fracture (FF), and periprosthetic fracture following TKA in patients who had and did not have preoperative chronic oral corticosteroid use. METHODS: A retrospective cohort analysis was conducted using a national database. Primary TKA patients who had chronic preoperative oral corticosteroid use were identified using Current Procedural Terminology and International Classification of Disease 9 and 10 codes. Exclusion criteria included malignancy, osteoporosis treatment, trauma, and < 2-year follow-up. Primary outcomes were 10-year cumulative incidence and hazard ratios (HRs) of all-cause revision (ACR), aseptic revision, PJI, FF, and periprosthetic fracture. A Kaplan-Meier analysis and a multivariable Cox proportional hazards model were utilized. Overall, 611,596 patients were identified, and 5,217 (0.85%) were prescribed chronic corticosteroids. There were 10,000 control patients randomly sampled for analysis. RESULTS: Corticosteroid patients had significantly higher 10-year HR of FF (HR; 95% confidence interval); P value (1.47; 1.34 to 1.62; P < .001)], ACR (1.21; 1.05 to 1.40; P = .009), and PJI (1.30; 1.01 to 1.69; P = .045) when compared to the control. CONCLUSIONS: Patients prescribed preoperative chronic oral corticosteroids had higher risks of ACR, PJI, and FF within 10 years following TKA compared to patients not taking corticosteroids. This information can be used by surgeons during preoperative counseling to educate this high-risk patient population about their increased risk of postoperative complications.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Haft M, Kubsad S, Pirtle JM, et al. Chronic Oral Corticosteroid Use and 10-Year Incidence of Major Complications Following Total Knee Arthroplasty. J Arthroplasty. 2024. PMID: 38649066. doi:10.1016/j.arth.2024.04.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。